Worm Breeder's Gazette 15(3): 2 (June 1, 1998)
These abstracts should not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the author.
26 Landsdowne Street Cambridge, MA 02139 (617) 494-8701
NemaPharm, an industry leader in the use of Caenorhabditis elegans for
human drug discovery, is continuing to hire scientists and associates
over the course of the next twelve months. NemaPharm is currently a
group of 26 highly dedicated researchers working to unlock disease
pathways, identify new therapeutic targets and discover drug candidates.
NemaPharm is a wholly-owned subsidiary of Axys Pharmaceuticals, a
!gene-to-drug! discovery company formed in January of 1998 from the
merger of Sequana Therapeutics (human genetics and genomics expertise)
and Arris Pharmaceutical (combinatorial and medicinal chemistry
expertise). Beginning in 1998, NemaPharm will be moving its entire
operations from Cambridge, MA to newly built-out laboratories on the
Axys campus in South San Francisco. New hires will be employed at the
California location although limited travel between sites may be
required through the Fall of 1998.
Throughout 1998, NemaPharm/Axys is seeking research scientists to join
our research teams. All levels from BS through PhD are encouraged to
apply.
Experience with C. elegans or a solid genetics background and the
desire to use model organisms is necessary.
NemaPharm/Axys offers a competitive salary and generous benefits,
including educational and relocation assistance.
Please mail or fax your CV together with a cover letter explaining your
interest and time frame to:
Human Resources
NemaPharm, Inc.
Suite 470
26 Landsdowne Street
Cambridge, MA 02139
(fax: 617-494-5101).
We are an Equal Opportunity Employer. To learn more about NemaPharm,
visit our web page at: http://www.nemapharm.com.